コンテンツへスキップ
Merck
  • Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature.

Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature.

Chemotherapy (1994-07-01)
I Marinová, V Szabadosová, O Brandeburová, V Krcméry
要旨

A case of Rhodotorula fungemia in a 13-year-old boy after neurosurgery successfully treated with miconazole and 5-flucytosine is reported. Intravascular catheter insertion, broad-spectrum anti-miocrobials, surgery, and immunosuppression are the main risk factors for fungemia.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
5-フルオロシトシン, nucleoside analog
Miconazole, European Pharmacopoeia (EP) Reference Standard
5-フルオロシトシン, European Pharmacopoeia (EP) Reference Standard